ES471984A1 - process for their preparation. - Google Patents
process for their preparation.Info
- Publication number
- ES471984A1 ES471984A1 ES471984A ES471984A ES471984A1 ES 471984 A1 ES471984 A1 ES 471984A1 ES 471984 A ES471984 A ES 471984A ES 471984 A ES471984 A ES 471984A ES 471984 A1 ES471984 A1 ES 471984A1
- Authority
- ES
- Spain
- Prior art keywords
- see diagramm
- diagramm
- see
- formula
- pharmaceutically usable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2201/00—Inorganic compounds or elements as ingredients in lubricant compositions
- C10M2201/02—Water
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2209/00—Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
- C10M2209/10—Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M2209/103—Polyethers, i.e. containing di- or higher polyoxyalkylene groups
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2209/00—Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
- C10M2209/10—Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M2209/103—Polyethers, i.e. containing di- or higher polyoxyalkylene groups
- C10M2209/104—Polyethers, i.e. containing di- or higher polyoxyalkylene groups of alkylene oxides containing two carbon atoms only
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2219/00—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
- C10M2219/04—Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions containing sulfur-to-oxygen bonds, i.e. sulfones, sulfoxides
- C10M2219/044—Sulfonic acids, Derivatives thereof, e.g. neutral salts
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2020/00—Specified physical or chemical properties or characteristics, i.e. function, of component of lubricating compositions
- C10N2020/01—Physico-chemical properties
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2040/00—Specified use or application for which the lubricating composition is intended
- C10N2040/20—Metal working
Abstract
1. An antibiotic composition, characterised in that it contains an active compound combination consisting of (1) beta-lactam antibiotics of the formula I : see diagramm : EP0000526,P9,F1 in which R1 represents see diagramm : EP0000526,P9,F2 see diagramm : EP0000526,P9,F3 see diagramm : EP0000526,P9,F4 see diagramm : EP0000526,P9,F5 see diagramm : EP0000526,P9,F6 and see diagramm : EP0000526,P9,F7 R2 represents phenyl, p-hydroxyphenyl or furyl, R3 represents H, OCH3 or OC2 H5 and wherein Y denotes see diagramm : EP0000526,P9,F8 or see diagramm : EP0000526,P9,F9 wherein T represents -O-CO-CH3 , -O-CO-NH2 , see diagramm : EP0000526,P9,F10 see diagramm : EP0000526,P9,F11 or see diagramm : EP0000526,P9,F12 and R4 is H, CH3 , -CH2 -COOH, -CH2 -SO3 H or -CH2 -CH2 -N(CH3 )2 or their pharmaceutically usable salts, in particular the sodium salts, or their various crystal or hydrate forms and (2) clavulanic acid of the formula II see diagramm : EP0000526,P9,F13 or its pharmaceutically usable salts or esters which can be split vivo, in particular its sodium salt.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19772733642 DE2733642A1 (en) | 1977-07-26 | 1977-07-26 | ANTIBIOTIC AGENTS |
Publications (1)
Publication Number | Publication Date |
---|---|
ES471984A1 true ES471984A1 (en) | 1979-10-16 |
Family
ID=6014859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES471984A Expired ES471984A1 (en) | 1977-07-26 | 1978-07-24 | process for their preparation. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0000526B1 (en) |
JP (1) | JPS5435219A (en) |
AT (1) | AT361618B (en) |
DE (2) | DE2733642A1 (en) |
DK (1) | DK330478A (en) |
ES (1) | ES471984A1 (en) |
IL (1) | IL55206A (en) |
IT (1) | IT1097330B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2964817D1 (en) * | 1978-09-06 | 1983-03-24 | Beecham Group Plc | Pharmaceutical compositions containing two beta-lactam derivatives |
EP0049968A1 (en) * | 1980-10-15 | 1982-04-21 | Beecham Group Plc | Pharmaceutical compositions |
DE3039243A1 (en) * | 1980-10-17 | 1982-05-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | ANTIBIOTICALLY EFFECTIVE COMBINATION OF MEDICINAL PRODUCTS |
JPS59104319A (en) * | 1982-12-06 | 1984-06-16 | Chugai Pharmaceut Co Ltd | Antibacterial agent and its kit |
JPS60146825A (en) * | 1984-01-10 | 1985-08-02 | Asahi Chem Ind Co Ltd | Oral drug pharmaceutical |
AT413015B (en) * | 2001-04-12 | 2005-10-15 | Sandoz Ag | Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2648770A1 (en) * | 1975-10-31 | 1977-05-05 | Beecham Group Ltd | (Alpha)-Heterocyclyl-carbonamido penicillins - derived from bicyclic heterocycles with a bridge head nitrogen atom |
-
1977
- 1977-07-26 DE DE19772733642 patent/DE2733642A1/en not_active Withdrawn
-
1978
- 1978-07-17 DE DE7878100407T patent/DE2860275D1/en not_active Expired
- 1978-07-17 EP EP78100407A patent/EP0000526B1/en not_active Expired
- 1978-07-24 JP JP8953678A patent/JPS5435219A/en active Pending
- 1978-07-24 IT IT26041/78A patent/IT1097330B/en active
- 1978-07-24 AT AT534478A patent/AT361618B/en not_active IP Right Cessation
- 1978-07-24 ES ES471984A patent/ES471984A1/en not_active Expired
- 1978-07-24 IL IL55206A patent/IL55206A/en unknown
- 1978-07-25 DK DK330478A patent/DK330478A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL55206A0 (en) | 1978-09-29 |
AT361618B (en) | 1981-03-25 |
DE2860275D1 (en) | 1981-02-05 |
EP0000526B1 (en) | 1980-11-12 |
IL55206A (en) | 1981-12-31 |
JPS5435219A (en) | 1979-03-15 |
EP0000526A1 (en) | 1979-02-07 |
DE2733642A1 (en) | 1979-02-08 |
IT7826041A0 (en) | 1978-07-24 |
IT1097330B (en) | 1985-08-31 |
DK330478A (en) | 1979-03-02 |
ATA534478A (en) | 1980-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8605405L (en) | PROCEDURE FOR PREPARING A SALT OF CLAVULANIC ACID | |
IE802174L (en) | Penicillin compounds | |
ES458241A1 (en) | Process for the preparation of the crystalline monohydrate of 7-(D- alpha -amino- alpha -(p-hydroxyphenyl)acetamido)-3-methyl-3-cephem-4-carboxylic acid | |
IE780899L (en) | Azetidinopyrrole derivatives | |
ES471984A1 (en) | process for their preparation. | |
AR248407A1 (en) | Crystalline beta-lactam hydrate | |
ES8304062A1 (en) | Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines. | |
IT7950680A0 (en) | CEPHALOSPORIN ANTIBIOTICS, COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR PRODUCING THEM | |
ES434976A1 (en) | Antibiotic pharmaceutical compositions | |
IT7950842A0 (en) | CEPHALOSPORIN ANTIBIOTICS COMPOSITIONS THAT CONTAIN THEM AND PROCEDURES FOR PRODUCING THEM | |
IT1143081B (en) | CEPHALOSPORIN ANTIBIOTICS COMPOSITIONS CONTAINING THEM AND PROCEDURE TO PRODUCE AND APPLY THEM | |
ES452637A1 (en) | Cephalosporin antibiotics | |
IT8047986A0 (en) | CEPHALOSPORIN ANTIBIOTICS PROCEDURE FOR PREPARING THEM AND COMPOSITIONS THAT CONTAIN THEM | |
IT7950823A0 (en) | CEPHALOSPORIN ANTIBIOTICS COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR PRODUCING THEM | |
GB2005247A (en) | Perhydro naphthalene derivatives | |
ES8403888A1 (en) | Bis-tetrazolemethyl thiols and their preparation. | |
IT7950681A0 (en) | CEPHALOSPORIN ANTIBIOTICS, COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR PRODUCING THEM | |
SE7612960L (en) | TIENAMYCIN DERIVATIVES | |
GB1332697A (en) | Benzodiazepine derivatives | |
GB2023142A (en) | Ureido Cephelosporins | |
ES8207218A1 (en) | Macrolide antibiotic | |
ATE31191T1 (en) | BETA-LACTA ANTIBIOTICS, PROCESS FOR THEIR MANUFACTURE AND AGENTS CONTAINING THEM. | |
ES8304997A1 (en) | Cephalosporin derivatives | |
ES423024A1 (en) | Novel acid compounds | |
IE45116L (en) | Preparation of 3-methylene-cephalosporins. |